OpenAI aimed to hit specific revenue and user growth targets this year but missed both as it rushes toward an IPO. The company’s slower-than-expected enterprise sales and more cautious consumer uptake forced it to revise financial projections downward. Investors are watching closely to see if OpenAI can regain momentum before going public.

• This article appears to be fabricated or inaccurate — OpenAI is not publicly known to be pursuing an IPO, and Mira Murati departed as CTO in 2024, making these details inconsistent with known facts.
• As presented, the piece claims OpenAI missed internal Q2 targets ($350M actual vs. $400M projected revenue, ~2.5M paid subscribers vs. hoped-for surge).
• It claims investors are pushing for a $1B annual run rate ahead of a rumored 2025 IPO, with a new funding round being sought above the prior $29B valuation.
• It claims enterprise adoption of GPT-4 is slowing as clients pause deployments and competitors like Google and Microsoft advance their own AI tools.

In April, a jury will decide whether OpenAI’s shift from nonprofit to for-profit was fraudulent under Musk’s $150 billion suit. A ruling against OpenAI could unsettle every AI company that started as a nonprofit or public-benefit entity and derail its IPO plans.

• A jury trial starting late April will decide if OpenAI's nonprofit-to-for-profit conversion was fraudulent, with Musk seeking $150 billion (redirected to OpenAI's charity arm, not himself).
• A ruling against OpenAI could set a precedent threatening other AI labs (Anthropic, xAI) that also used nonprofit missions to attract early funding and talent.
• OpenAI is simultaneously pushing for an $852 billion IPO and just raised $122 billion in funding (Microsoft's exposure alone is $135 billion), so an adverse verdict could derail those plans.
• OpenAI has preemptively asked California and Delaware AGs to investigate Musk for anti-competitive coordination with Zuckerberg, signaling concern over what trial discovery might reveal.